NDC 57926-465-01 - Salix
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 57926-465
- Requested NDC
- 57926-465-01
- Package NDCs from labels
- 57926-465-01
- Manufacturer
- Merck Sharp & Dohme Corp.
- Effective date
- 2024-11-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SALIX ® (furosemide injection) | Merck Sharp & Dohme Corp. | 2024-11-15 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57926-465-01 | Salix | 1 in 1 CARTON | INJECTION | 1 | 5 | |
| 57926-465-01 | Salix | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION | 50 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Furosemide | FUROSEMIDE | Proficient Rx LP | ce84359c-2f76-421a-9b2b-79b1c2be2f20 | 2021-01-01 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Gland Pharma Limited | 644704c0-e6a5-4804-bfa6-795c8f83aa7a | 2020-07-03 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Aphena Pharma Solutions - Tennessee, LLC | 1d2733ac-6fa6-44d1-96d4-f1a698045ad2 | 2018-04-18 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Aphena Pharma Solutions - Tennessee, LLC | 6fbf7f3d-7566-44d5-9507-c4460238fc91 | 2018-02-09 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.